The Effect of the NHS Breast Screening Programme on Breast Cancer Mortality in England and Wales, 1990-1998: Statement

NHS Cancer Screening Programme Logo
Feedback and Enquires to the NHS Cancer Screening Programmes
NHS Cancer Screening
NHS Cancer Screening Press Room
NHS Breast Screening Programme
NHS Cervical Screening Programme
NHS Bowel Cancer Screening Programme
NHS Prostate Cancer Risk Management

Breast Screening Annual Review (UK)
Breast screening statistics
Breast Screening Equipment Guidance

Research Literature Online Database

Published 15th September, 2000

Julietta Patnick, National Coordinator of the NHS Cancer Screening Programmes said:

"This is welcome evidence that proves that the breast screening programme saves women's lives in the UK. This research confirms that we are on the way to a 25% reduction in mortality from breast cancer, and we are confident that we will reach our target. Indeed, we are now detecting more small cancers than ever before - cancers impossible to feel with the human hand. This makes earlier and less drastic treatment possible, and gives women a greater chance of survival."

"In 1997/98 we screened more than one and a quarter million women, and detected nearly eight thousand cancers. We are proud of the breast screening programme and it's international reputation, and are looking forward to extending the invitations for screening to 65-70 year old women and to introducing double-view mammography to all screening rounds in the future."

Notes for editors:

  1. It is estimated that we should see the full effects of the national breast screening programme over the 10 years between 2000 and 2010.

  2. The net effect of screening plus contributions from other factors including treatment could see the mortality rate in the year 2010 in women aged 55-69 at about half that of the rate in 1990.

  3. In 1997/98:

  • The programme detected 7,932 cancers - an increase of 11% on 1996/97

  • 3,381 cancers smaller than 15mm were detected - an increase of 7 per cent on 1996/97. Cancers smaller than 15mm are impossible to feel with the human hand, and detecting these cancers through screening allows women to be treated earlier, with less radical treatments and gives them a greater chance of survival.

  • 1,718 cancers were detected in situ (those that have not yet spread beyond the breast ducts) representing an increase of 20% on 1996/97. Detecting these cancers in situ significantly increases the rate of cure. Should the cancers be left, most might be expected to become fully invasive cancers.

Search this site for:
Breast Screening Publications Index

Breast screening programme index

What happens at a
breast screening unit?

What are the risks of breast screening?

Frequently Asked Questions (FAQs)

Breast awareness

Benign breast disease

DCIS (Ductal Carcinoma
in Situ)

Diethylstilbestrol (DES) exposed women

Breast cancer

Quality assurance

Training

Programme statistics

Archived statistics bulletins

Research

Publications

Programme posters

Archive

Useful links

Home | Breast Screening | Cervical Screening | Bowel Cancer Screening | Prostate Cancer Risk Management | Breast Screening News | Contact NHS Screening ]

The national office can be contacted at:

NHS Cancer Screening Programmes
Fulwood House
Old Fulwood Road
SHEFFIELD S10 3TH

Tel: 0114 271 1060
Fax: 0114 271 1089
E-mail: [email protected]

Press and media enquiries should be made to:

NHS Cancer Screening Press Office
100 Gray's Inn Road
London
WC1X 8AL

Tel: 020 7400 4499
Fax: 020 7400 4481
E-mail: [email protected]

breastscreen/news/001.html
Designed and hosted by The Net Effect
©NHS Cancer Screening Programmes